click below
click below
Normal Size Small Size show me how
NationalBoardReview
Classifications
Question | Answer |
---|---|
Normal Blood Pressure | Systolic: <120 mmHg Diastolic: <80 mmHg |
Pre-Hypertensive Blood Pressure | Systolic: 120-139 mmHg Diastolic: 80-89 mmHg |
Stage I Hypertension | Systolic: 140-159 mmHg Diastolic: 90-99 mmHg |
Stage II Hypertension | Systolic: >160 mmHg Diastolic: >100 mmHg |
AAP Case Type I | Gingival Disease Inflammation of the gingiva characterized clinically by changes in color, gingival form, position, surface appearance, and presence of bleeding and/or exudates. |
AAP Case Type II | Early Periodontitis Progression of the gingival inflammation into the deeper periodontal structures and alveolar bone crest, with slight bone loss. There is usually a slight loss of connective tissue attachment and alveolar bone. |
AAP Case Type III | Moderate Periodontitis A more advanced stage with increased destruction of the periodontal structures and noticeable loss of bone support, possibly accompanied by an increase in tooth mobility. There may be furcation involvement in multirooted teeth. |
AAP Case Type IV | Advanced Periodontitis Further progression of periodontitis with major loss of alveolar bone support usually accompanied by increased tooth mobility. Furcation involvement in multirooted teeth. |
Class I Dental Caries Classification | Cavities in pits or fissures Occlusal surfaces of premolars and molars Facial and lingual surfaces of molars Lingual surfaces of maxillary incisors |
Class II Dental Caries Classification | Cavities in proximal surfaces of premolars and molars |
Class III Dental Caries Classification | Cavities in proximal surfaces of incisors and canines that do not involve the incisal angle |
Class IV Dental Caries Classification | Cavities in proximal surfaces of incisiors or canines that involve the incisal angle |
Class V Dental Caries Classification | Cavities in the cervical 1/3 of facial or lingual surfaces (not pit and fissures) |
Class VI Dental Caries Classification | Cavities on incisal edges of anterior teeth and cusp tips of posterior teeth |
Mesognathic | Having slightly protruded jaws, which give the facial outline a relatively flat appearance – straight profile |
Retrognathic | Having a prominent maxilla and a mandible posterior to its normal relationship – convex profile |
Prognathic | Having a prominent, protruded mandible and normal (usually) maxilla – concave profile |
Normal Overbite | An overbite is considered normal when the incisal edges of the maxillary teeth are within the incisal third of the mandibular teeth. |
Moderate Overbite | An overbite is considered moderate when the incisal edges of the maxillary teeth appear within the middle third of the mandibular teeth. |
Deep (Severe) Overbite | Deep (severe): When the incisal edges of the maxillary teeth are with in the cervical third of the mandibular teeth Very deep: When in addition the incisal edges of the mandibular teeth are in contact with the maxillary lingual gingival tissue. |
Extrinsic Strain | External surface of the tooth and may be removed by procedures of tooth brushing, scaling, and/or polishing. |
Intrinsic Strain | Stain within the tooth substance and cannot be removed by techniques of scaling or polishing. |
Exogenous Strain | or originate from sources outside the tooth. |
Endogenous Strain | Develop or originate from within the tooth. |
ASA I | Without systemic disease; a normal, healthy patient with little or no dental anxiety |
ASA II | Mild systemic disease or extreme dental anxiety |
ASA III | Systemic disease that limits activity but is not incapacity |
ASA IV | Incapacitating disease that is a constant threat to life |
ASA V | Patient is moribund and not expecting to survive |
Gingival Embrasures Type I | Interdental papilla fills the gingival embrasure |
Gingival Embrasures Type II | Slight to moderate recession of the interdental papilla |
Gingival Embrasures Type III | Extensive recession or complete loss of the interdnetal papilla |
Periodontal infection before treatment | Anaerobic Gram – Motile Spirochetes, motile rods; pathogenic Very high total court of all types of micrograms Many leukocytes |
Periodontal health after treatment | Aerobic Gram + Nonmotile Coccoid forms; nonpathogenic Much lower total counts of all types of microorganisms Lower leukocyte count |
Class I Classifications of Cleft lip and Cleft Palate | Cleft of the top of the uvula |
Class II Classifications of Cleft lip and Cleft Palate | Cleft of the uvula (bifid uvula). |
Class III Classifications of Cleft lip and Cleft Palate | Cleft of the soft palate. |
Class IV Classifications of Cleft lip and Cleft Palate | Cleft of the soft and hard palates. |
Class V Classifications of Cleft lip and Cleft Palate | Cleft of the soft and hard palates that continues through the alveolar ridge on one side of the pre-maxilla; usually associated with cleft lip of the same side. |
Class VI Classifications of Cleft lip and Cleft Palate | Cleft of the soft and hard palates that continues through the alveolar ridge on both sides, leaving a free premaxilla; usually associated with bilateral cleft lip. |
Class VII Classifications of Cleft lip and Cleft Palate | Submucous cleft in which the muscle union is imperfect across the soft palate. The palate is short, the uvula is often bifid, a groove is situated at the midline of the soft palate, and the closure to the pharynx is incompetent. |
Torus Palatinus | Bony enlargement located over the midline of the palate. |
Torus Mandibularis | Bony mass generally lovaed on the lingual in the region of the premolars. |
Exostosis | A bony protuberance generally located on the buccal aspects of maxilla and/or mandible. |
Simple partial seizures (without loss of consciousness) | With motor signs With somatosensory or special sensory symptoms With autonomic symptoms With psychotic symptoms |
Complex partial seizures | Simple partial onset followed by impairment of consciousness With impairment of consciousness at onset |
Generalized seizures - Nonconvulsive seizures | Absence seizures Atypical absence seizures Myoclonic seizures Atonic seizures |
Generalized seizures - Convulsive seizures | Tonic-clonic seizures Tonic seizures Clonic seizures |
Unclassified epileptic seizures | Seizures lasting over 5 minutes and a medical emergency |
Class I Tooth Mobility | Slight mobility, up to 1 mm of horizontal displacement in a facial-lingual direction |
Class II Tooth Mobility | Moderate mobility, >1 mm but <2 mm of horizontal displacement in a facial-lingual direction |
Class III Tooth Mobility | Severe mobility, >2 mm of displacement in a facial-lingual direction or vertical displacement (tooth depressible in the socket) |
Class I Furcation Classification | The concavity – just above the furcation entrance – on the root trunk can be felt with the probe tip; however, the furcation probe cannot enter the furcation area. |
Class II Furcation Classification | The probe is able to partially enter the furcation – extending approximately one third of the width of the tooth – but it is not able to pass completely through the furcation. |
Class III Furcation Classification for Mandibular Molars | The probe passes completely through the furcation between the mesial and distal roots. |
Class Class III Furcation Classification for Maxillary Molars | The probe passes between the mesiobuccal and distobuccal roots and touches the palatal root. |
Class IV Furcation Classification | Same as a class III furcation involvement except that the entrance to the furcation is visible clinically owing to tissue recession. |
Low Caries Risk Children 0-5 | No carious lesions in the past year Mother or caregiver do not have caries Well coalesced pits and fissures Regular re-care intervals Appropriate fluoride use Low count of cariogenic bacteria |
Low Caries Risk Children >6 Years & Adults | No carious lesions in the past 3 yrs. Sound restorations (no plaque retention) Minimal to no plaque/inflammation Optimum fluoride use Regular recare intervals Visually adequate salivary flow |
Moderate Caries Risk Children 0-5 | 1 carious lesion restored in the past year Deep pits and fissures Localized areas of plaque and inflammation White spot lesions &/or IP radiolucencies Irregular re-care intervals Inadequate fluoride exposure |
Moderate Caries Risk Children >6 Years & Adults | 1 carious lesion restored in the past year Exposed root surfaces Depp pits and fissures/ developmnt defects Localized moderate plaque/inflammation White spot lesions Recreational drug use |
High Caries Risk Children 0-5 | Mother or caregiver w/ active caries Inappropriate bottle feeding/nursing Carious/white spot lesion present Frequent sugar intake Inadequate fluoride us/ irregular re-care intv. Developmental conditions |
High Caries Risk Children >6 Years & Adults | Carious lesions present currently Restored caries within past 3 yrs Xerostomia Fixed or removable appliances High levels of cariogenic bacteria Inadequate saliva flow High levels of cariogenic bacteria |
Radiograph Caries E0 | Sound, no caries |
Radiograph Caries E1 | Caries in the outer ½ of enamel |
Radiograph Caries E2 | Caries into the inner ½ of enamel to DEJ |
Radiograph Caries D1 | Caries through DEJ, into the outer 1/3 of dentin |
Radiograph Caries D2 | Caries into the middle 1/3 of the dentin |
Radiograph Caries D3 | Caries into the inner 1/3 of the dentin |
Type I Overhang | Less than 1/3 of interproximal space. Treated with margination procedure and re-polishing of restoration. May be detected radiographically. |
Type II Overhang | 1/3 to 1/2 of interproximal embrasure space. Treated with margination procedure if predicted final result is good (considering prognosis of tooth, complexity, and cost of replacement). Usually radiographically and clinically detectable. |
Type III Overhang | than 1/2 of interproximal embrasure space. Treated with replacement of restoration. Clinical and radiographically detectable. |
Schedule I = C-I Controlled Substances Classifications | The drugs and other substances in this schedule have no legal medical uses except research. They have a high potential for abuse. They include selected opiates such as heroin, opium derivatives, and hallucinogens. |
Schedule II = C-II Controlled Substances Classifications | The drugs and other substances in this schedule have legal medical uses and a high abuse potential which may lead to severe dependence. They include former “Class A” narcotics, amphetamine, barbiturates, and other drugs. |
Schedule III = C-III Controlled Substances Classifications | The drugs and other substances in this schedule have legal medical uses and a lesser degree of abuse potential which may lead to moderate dependence. They include former “Class B” narcotics and other drugs. |
Schedule IV = C-IV Controlled Substances Classifications | The drugs and other substances in this schedule have legal medical uses and low abuse potential which may lead to moderate dependence. They include barbiturates, benzodiazepines, propoxyphenes, and other drugs. |
Schedule V = C-V Controlled Substances Classifications | The drugs and other substances in this schedule have legal medical uses and low abuse potential which may lead to moderate dependence. They include narcotic cough preparations, diarrhea preparations, and other drugs. |
FDA Pregnancy Category A | Controlled studies in pregnant women fail to demonstrate a risk to the fetus in the 1st trimester with no evidence of risk in later trimesters. The possibility of fetal harm appears remote. |
FDA Pregnancy Category B | Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women, or animal-reproduction studies have shown an adverse effect that was not confirmed in controlled studies in women in the 1st trime |
FDA Pregnancy Category C | Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal effects or other) and there are no controlled studies in women, or studies in women and animals are not available. Drugs should be given only if the potent |
FDA Pregnancy Category D | There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (eg, if the drug is needed in a life-threatening situation or a serious disease for which safer drugs cannot be used or are inef |
FDA Pregnancy Category X | Studies in animals/humans beings have demonstrated fetal abnormalities or there is evidence of fetal risk based on human experience, or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contrai |